Monthly Archives: January 2020

Nasdaq Names Roland Chai Global Chief Risk Officer

Chai, most recently Head of Post-Trade at Hong Kong Exchange, will oversee Nasdaq’s global risk program

NEW YORK and STOCKHOLM, Sweden, Jan. 31, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Roland Chai, most recently Head of Post-Trade at Hong Kong Exchange, will join the executive leadership team as Chief Risk Officer (CRO). Chai will be responsible for developing, reviewing and maintaining Nasdaq’s global risk program. He will report to Adena Friedman, President and CEO, Nasdaq.

“Risk management is an essential part of Nasdaq’s global business and operations,” said Adena Friedman, President and CEO, Nasdaq. “Nasdaq is committed to building and maintaining an industry leading culture of risk management that is able to support our long-term objectives. Roland brings extensive experience in establishing and implementing risk frameworks across functions as well as strong management capabilities that will further strengthen and enhance our decision making and business operating processes. We look forward to welcoming Roland to the Nasdaq team.”

Chai will assume his new role on June 1, 2020, and will be based in Stockholm, Sweden.

“Within the capital markets, Nasdaq has demonstrated its commitment to globalizing its business and building an advanced technology company,” said Chai. “Nasdaq also is recognized as a leader in providing risk management solutions for its own markets, regulators and other industries. I’m thrilled to be joining the company to continue bolstering its global, enterprise-wide risk culture.”

Chai most recently served as Head of Post-Trade at Hong Kong Exchange where he oversaw clearing and risk management functions across equities and fixed income, currencies and commodities, as well as the exchange’s market surveillance. During his tenure, Chai re-established risk frameworks across Exchange, Listings, Mainland Commodities, Trading, and Clearing departments, amongst other accomplishments. He previously served as Group Risk Officer and Head of Clearing at Hong Kong Exchange. Prior to joining Hong Kong Exchange, Chai served as Head of Equities at LCH.Clearnet.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at



Yan-yan Tong
Mobile: +46 (0)73 449 66 83


Taconic Biosciences Launches New Immuno-oncology Mouse Model

Expands and Broadens Taconic Biosciences’ Immuno-oncology Portfolio Application

RENSSELAER, N.Y., Jan. 31, 2020 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model.

Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease.  Animal models used in this therapeutic development include special mice, which model human immune system function.  Taconic’s immuno-oncology portfolio is built on the CIEA NOG mouse®, a severely immunodeficient mouse with diverse applications based on its improved ability to engraft human cells and tissues.  B2m-NOG is an important addition to this portfolio because it significantly extends the study window after human peripheral blood mononuclear (PBMC) cell engraftment, providing more time to assess reactions to target drugs.  The extended study window dramatically expands immuno-oncology study types that can be run using the B2m-NOG model compared with more expensive and time-consuming options, such as hematopoietic stem cell-engrafted models. Taconic also offers B2m-NOG mice pre-engrafted with human PBMCs.

“Taconic is in a unique position to impact immuno-oncology research,” commented Dr. Michael Seiler, vice president of commercial products at Taconic. “Combining the extended study windows possible with B2m-NOG with Taconic’s expert consultation from PhD-level field application scientists enables our customers to quickly integrate this new tool into their experimental workflow.”

To learn more about Taconic Biosciences’ humanized model portfolio, please contact Taconic at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

 MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 31, 2020: Lyfebulb, a patient empowerment platform that connects patients with industry to support user-driven innovation toward solutions in chronic disease, and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, announce that Russell LaMontagne of Boston Immune Technologies and Therapeutics was chosen as the winner of the Lyfebulb-Helsinn Innovation Award, and Cesare Spadoni, PhD, of Oncoheroes Biosciences was chosen as the winner of the Squinto-LePera Award by Lyfebulb. In addition, the jury decided to award Michael Stein, PhD, of Valo Therapeutics a third grant. The Awards recognize outstanding Patient Entrepreneurs building groundbreaking companies to advance the prevention, diagnosis, management or care of cancer.

Boston Immune Technologies and Therapies is developing immune-based therapies for cancer to help patients by making treatments more efficacious, cost effective and time efficient. Oncoheroes Biosciences exclusively focuses on the discovery and development of better drugs to help children and adolescents with cancer. Valo Therapeutics is developing novel, patented therapeutic immunotherapy platforms to help cancer patients by uniquely addressing all four objectives key to successful cancer therapy.

Eleven finalists, all of whom represent companies founded by cancer patients, cancer survivors or those with loved ones affected by cancer, were invited to compete at the Lyfebulb-Helsinn Cancer Innovation Summit on January 30, 2020, at the Grimaldi Forum in Monaco during the 14th Monaco Biennale of Oncology. The Summit kicked off with a presentation by Dr. Giulio Draetta, Chief Scientific Officer of MD Anderson, that highlighted the new direction his organization is taking to drive innovation in cancer research.  An independent panel of judges, which included diverse experts in the cancer, healthcare and business communities, listened to the pitches and selected Russell and Cesare as the winners of the two $25,000 monetary grants, and added Michael with a $5,000 grant, to further develop their potential solutions.

“The outstanding diversity and innovations of the 11 finalists attest to the growing reputation of the Challenge that we are running together with Helsinn for a third year in a row.  Additionally, this year, during the Summit, we included an inspirational, moving presentation by a two-time cancer survivor, Kimberly Irvine. We saw firsthand that the combination of patients and care partners working alongside industry is an important key to success,” said Dr. Karin Hehenberger, CEO and Founder of Lyfebulb.

Riccardo Braglia, Helsinn Group Vice Chairman and CEO, said, “The caliber of submissions for this year’s awards was extremely high and we would like to congratulate all those who made it to the Summit. We congratulate Russell, Cesare and Michael and would also like to extend our thanks to the expert panel of judges who had to choose between so many worthy finalists. These awards are testament to the many entrepreneurs out there who are using their own personal experiences to bring innovation and new solutions to the challenges of cancer. Helsinn is proud to support innovation of this quality and looks forward to supporting budding entrepreneurs in coming years.”

About Lyfebulb

Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients and industry to support user-driven innovation. Grounded with its strong foundation in diabetes, the company has expanded disease states covered into cancer, inflammatory bowel disease, multiple sclerosis, mental health, migraine and transplantation.

See, Facebook, Twitter, Instagram, Lyfebulb LinkedIn, and Karin Hehenberger LinkedIn.

About the Helsinn Groups

Helsinn is a privately-owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland, the U.S., Monaco and China, as well as a product presence in approximately 190 countries globally.

To learn more about Helsinn Group please visit

About Helsinn Investment Fund S.A., SICAR

The Helsinn Investment Fund is focused on investments in areas of high unmet patient need. Backed by the Helsinn Group, and guided by Helsinn’s core values of quality, integrity and respect, Helsinn Investment Fund aims to help companies with innovative technologies to transform new ideas into commercial solutions with the potential to impact health-related quality of life of patients.

Drawing on Helsinn’s over 40 years of investment into research and development and commercial expertise, the investment fund selects companies with technologies in a range of areas including cancer therapeutics and diagnostics, cancer supportive care, metabolic and gastrointestinal disorders, and dermatology conditions.

For more information, visit

About Helsinn International Services sarl

Helsinn International Services sarl is the Helsinn subsidiary which provides a range of advisory services and strategic activities to the Group and its specific companies. In particular, it acts as the advisory company to Helsinn Investment Fund.

For more information:
Helsinn Group Media Contact
Paola Bonvicini
Group Head of Communication
Lugano, Switzerland
Tel: +41 (0) 91 985 21 21
For more information, please visit and follow us on Twitter, LinkedIn and Vimeo.

Lyfebulb Media Contact:
Karin Hehenberger, MD, PhD
CEO & Founder, Lyfebulb
Phone: + 1 917-575-0210

FAO + Japan: A growing partnership towards sustainable development

Japan has been among FAO’s foremost partners since the country joined the Organization in 1951, working to build food security and promoting the sustainable use of natural resources.

The country’s financial contributions, expertise and human capital are vital to FAO’s work on a broad range of topics, including international standard-setting, climate change mitigation and adaptation, response to transboundary plant and animal pests and diseases, nutrition, Globally Important Agricultural Heritage Systems (GIAHS), emergency response and resilience building.

Supporting global food governance

FAO contributes to the daily lives of people around the world by developing and promoting international standards, guidelines and codes of conduct around the production and trade of food. Japan helps to boost these efforts through its support to major covenants whose governing bodies are hosted in FAO: the Codex Alimentarius Commission, the International Plant Protection Convention, and the International Treaty on Plant Genetic Resources for Food and Agriculture.

Enhancing sustainable food value chains and nutrition

Japan supports FAO’s work on food systems through a wide range of activities, contributing to ensuring that development within agriculture is people-centred and leads to improved access, availability and consumption of healthy foods. Within the ASEAN region, Japan’s contribution of USD 1.3 million between 2016 and 2019, helped to develop effective and inclusive food value chains in Indonesia and the Philippines, by training actors in selected value chains on marketing, business management, and good manufacturing and agricultural practices.

Thanks to Japan’s support (USD 1.5 million between 2017 and 2021), FAO is also working to ensure that food systems are conducive to healthy diets for better nutrition, through awareness raising and capacity building initiatives. The project is collaborating with universities in Ghana, Kenya and Viet Nam to incorporate FAO capacity development resources into their existing learning programmes, ensuring the dissemination of knowledge and skills to foster continuous innovation on nutrition. Likewise, the initiative is strengthening the capacities of small and medium enterprises to adopt nutrition-sensitive practices and approaches in their business models.

Source: Food and Agriculture Organization of the United Nations

US-Led Initiative Aims to Make Mark on Global Infrastructure Development

WHITE HOUSE – Can a conscientious private sector in Western countries counter China’s trillion-dollar “One Belt, One Road” initiative (OBOR) that is generously financed by state-owned banks and companies, often criticized for pushing recipient countries into debt and known for few controls on corruption and environmental destruction?

That is a question a new U.S.-led certification plan, the Blue Dot Network, seeks to answer by issuing “as a globally recognized seal of approval for major infrastructure projects, letting people know the projects are sustainable and not exploitative,” according to the State Department.

A “blue dot” will be awarded to projects the initiative endorses.

The first meeting of the Blue Dot Network’s embryonic steering committee was held in Washington this week, with Australia and Japan as partners.

Blue Dot has “enormous potential,” according to the State Department’s Keith Krach, who is under secretary for economic growth, energy and the environment.

“I’ve probably had 60 bilaterals with developing nations from Africa, South America, ASEAN countries, Central Europe and Central Asia and they’re crying out for our leadership � the nations assembled here,” said Krach at Thursday’s session. “It’s not just for good infrastructure. It’s for trusted infrastructure.”

The Blue Dot Network will not itself directly invest in projects, leading to questions as to whether it will have much impact if it is merely recommending certain initiatives for private bank financing.

“This is not intended to exclude anybody for membership. This is an open platform,” said U.S. Deputy National Security Adviser Matt Pottinger, as he initiated the steering committee’s first formal meeting at the Eisenhower Executive Office Building, adjacent to the White House.

At present the project is led by the U.S. International Development Finance Corporation (boasting access to $60 billion in capital), in partnership with the government-owned Japan Bank for International Cooperation and Australia’s Department of Foreign Affairs.

China expected to ‘fight back hard’

Still it pales in comparison to China’s OBOR, which is cooperating with nearly 140 countries and several dozen international organizations.

“I am sure the Chinese will fight back hard,” former U.S. ambassador to the Asian Development Bank Skipp Orr told VOA.

Analysts say it is premature to predict how effective the Blue Dot will be and whether it will be distinctive from China’s OBOR.

“I think this idea, there is a dichotomy between the Chinese-friendly projects and the Blue Dot Network projects is probably a simplification of what we’re going to see,” according to Nicolas Veron, senior fellow at the Peterson Institute for International Economics.

Noting that OBOR is a major priority for the China-led Asian Infrastructure Investment Bank (AIIB), Orr added that the “Chinese will likely be pretty defensive about any effort that seems to chip away at AIIB priorities.”

Blue Dot certification, according to Pottinger, will draw on existing good principles already set by other groups and international finance institutions and is not meant to create “a barrier to obtaining support for infrastructure projects, but rather to present Blue Dot Network membership as an advantage that will allow those projects to attract more capital than they might have otherwise be attracting.”

Future partners

Besides U.S., Japanese and Australian officials, observers from several other governments considering joining the committee attended the meetings Thursday and Friday.

U.S. officials, who invited five news outlets, including VOA, to attend the first 30 minutes of the meeting on Thursday, declined to name which other countries were in attendance, only saying they included several countries across Europe and North America.

“Other partners will be announced in due course,” a senior U.S. government official told VOA.

Pottinger compares Blue Dot to a gold standard or a Michelin star given to high-quality restaurants.

“We have to make a Michelin three star (the highest rating) through this Blue Dot Network,” responded Tadashi Maeda, a governor for the Japan Bank for International Cooperation.

“The question is how do we move forward? How do we handle the financial capital?” asked Ambassador Katrina Cooper, the deputy chief of mission at Australia’s embassy in Washington.

Cooper said Australia strongly supports Blue Dot because it is a “very powerful initiative.”

The United States has committed $2 million of seed money for the steering committee, Krach announced Thursday.

The NSC official issued a public invitation to all other G-7 members to come on board.

U.S. officials are particularly interested to get India, a rival and neighbor to China, to come on board.

Trump is to travel to India in late February, a trip expected to focus on bilateral trade and investment.

“An obvious question about Blue Dot,” noted Veron, “is depending on the results of the U.S. election in November will it be sustained?”

Source: Voice of America

UN welcomes constructive dialogue between ASEAN, China: Sec-Gen Guterres

UNITED NATIONS, United Nations Secretary-General Antonio Guterres said that the UN welcomes the constructive dialogue between the 10-member Association of Southeast Asian Nations (ASEAN) and China, while noting that ASEAN plays a key role in the regional peace and security architecture.

The United Nations also welcomes the constructive dialogue between ASEAN and China towards the maintenance of regional peace and maritime security, the UN chief told the Security Council meeting on cooperation between the United Nations and ASEAN.

We look forward to the conclusion of a ‘Code of Conduct’ in the South China Sea to help prevent maritime disputes, said the secretary-general.

ASEAN plays a key role in the regional peace and security architecture, including bringing together major regional powers within ASEAN-led fora, he added.

We encourage ASEAN to use that great convening power to effectively and creatively address peace and security threats in the broader Asia-Pacific region, said the UN chief.

Guterres commended ASEAN’s contributions to helping ease the situation on the Korean Peninsula.

Noting that the situation on the Korean Peninsula remains of deep concern, the UN chief said that through public and quiet diplomacy, including by hosting historic meetings in Singapore and Hanoi, the ASEAN region has contributed to efforts to promote sustainable peace and security, and the complete and verifiable denuclearization of the Korean Peninsula, Guterres said. � NNN-XINHUA

Source: NAM News Network

Optiwave Introduces OptiSPICE plugin for Tanner

Optiwave’s OptiSPICE Plugin enables optoelectronic circuit simulation in Tanner EDA tools from Mentor, a Siemens business

OTTAWA, Jan. 29, 2020 (GLOBE NEWSWIRE) — Optiwave Systems Inc., the leading provider of optical component and system design tools, today announced the immediate availability of its OptiSPICE plugin for Tanner. As a result of a collaboration between Optiwave and Mentor, a Siemens business, OptiSPICE optical models supporting Tanner GPIC PDK are now available.

The seamless integration of OptiSPICE optical models into the Tanner photonic flow helps enables the simulation of complex optoelectronic circuits from schematic and/or mask layout. Time and frequency domain simulations with experimentally or numerically verified electrical and optical models can now be launched from an S-Edit schematic and evaluated using a single simulation engine, T-Spice. With the addition of OptiSPICE optical models, Mentor’s Tanner photonic flow can offer an excellent environment for optoelectronic circuit designs with highly nonlinear components, control circuits and feedback loops.

“A co-simulation interface with OptiSPICE and T-Spice has been co-developed by the two companies. This helps enable simulation between the optical domain and the transistor domain to validate that the PIC works in conjunction with the interface circuitry,” said Greg Lebsack, General Manager, IC Design Solutions at Mentor, a Siemens business. “The photonic and interface designs now can be validated simultaneously via cross domain simulation.”

For information on news and updates on this software integration package:

About Optiwave Systems Inc.
Optiwave ( is a leading provider of engineering design software products for photonic, biophotonic, and system design engineers. Optiwave provides a comprehensive variety of optical component and system design tools to hundreds of leading high-technology businesses and academic institutions. An established community of engineers and scientists in over seventy countries supports Optiwave’s hallmark of achievements in Canadian business for 25 years.

Optiwave is headquartered in Ottawa, Canada with an established distribution network throughout the Americas, Europe, and Asia. To download a free evaluation license, please visit Optiwave’s online resource centre at

Note: A list of relevant Siemens trademarks can be found here.

Press Contact
Sawyer (Jie) Ge
Optiwave Systems Inc.
613-224-4700 x249